{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arthritis+Multiple+Joint&page=9", "query": { "condition": "Arthritis Multiple Joint", "page": 9 }, "page_size": 10 }, "pagination": { "page": 9, "page_size": 10, "total_count": 344, "total_pages": 35, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arthritis+Multiple+Joint&page=10&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Arthritis+Multiple+Joint&page=8&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-22T16:58:30.211Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02301234", "title": "Study of Safety, Efficacy of Fulranumab Adjunctive Use in OA of Hip or Knee, PAI3007", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Osteoarthritis", "Pain" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Fulranumab 1 mg", "type": "DRUG" }, { "name": "Fulranumab 3 mg", "type": "DRUG" }, { "name": "Celecoxib 100 mg", "type": "DRUG" }, { "name": "Celecoxib 100 mg Matching Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Janssen Research & Development, LLC", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "99 Years", "sex": "ALL", "summary": "18 Years to 99 Years" }, "enrollment_count": 111, "start_date": "2015-03-25", "completion_date": "2016-09-19", "has_results": false, "last_update_posted_date": "2017-09-14", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 32, "location_summary": "Glendale, Arizona • Phoenix, Arizona • Tucson, Arizona + 29 more", "locations": [ { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "Anaheim", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02301234" }, { "nct_id": "NCT03387735", "title": "Multiple Chronic Conditions for Older Adults", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Chronic Disease" ], "interventions": [ { "name": "Treatment as usual (TAU) + Internet", "type": "OTHER" }, { "name": "TAU + ElderTree", "type": "BEHAVIORAL" } ], "intervention_types": [ "OTHER", "BEHAVIORAL" ], "sponsor": "University of Wisconsin, Madison", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "65 Years", "maximum_age": null, "sex": "ALL", "summary": "65 Years and older" }, "enrollment_count": 346, "start_date": "2018-01-01", "completion_date": "2021-06-29", "has_results": true, "last_update_posted_date": "2022-09-01", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 1, "location_summary": "Madison, Wisconsin", "locations": [ { "city": "Madison", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT03387735" }, { "nct_id": "NCT02701985", "title": "A Study to Assess the Efficacy of RO5459072 in Participants With Primary Sjogren's Syndrome", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Sjogren's Syndrome" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "RO5459072", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 75, "start_date": "2016-07-05", "completion_date": "2017-07-10", "has_results": true, "last_update_posted_date": "2018-08-01", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 12, "location_summary": "Beverly Hills, California • Denver, Colorado • Baton Rouge, Louisiana + 9 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Baton Rouge", "state": "Louisiana" }, { "city": "Baltimore", "state": "Maryland" }, { "city": "Ann Arbor", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02701985" }, { "nct_id": "NCT01119859", "title": "A Study of Tocilizumab (RoActemra/Actemra) Versus Adalimumab in Patients With Rheumatoid Arthritis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Tocilizumab", "type": "DRUG" }, { "name": "Adalimumab", "type": "DRUG" }, { "name": "Placebo to tocilizumab", "type": "DRUG" }, { "name": "Placebo to adalimumab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 326, "start_date": "2010-05", "completion_date": "2012-01", "has_results": true, "last_update_posted_date": "2013-02-11", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 33, "location_summary": "Anniston, Alabama • Birmingham, Alabama • Scottsdale, Arizona + 30 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Birmingham", "state": "Alabama" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Hot Springs", "state": "Arkansas" }, { "city": "Little Rock", "state": "Arkansas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01119859" }, { "nct_id": "NCT00985127", "title": "Study to Evaluate the Urate-Lowering Activity and Safety of Oral BCX4208 Administered in Subjects With Gout", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Gout" ], "interventions": [ { "name": "placebo", "type": "DRUG" }, { "name": "BCX4208", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "BioCryst Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "69 Years", "sex": "ALL", "summary": "18 Years to 69 Years" }, "enrollment_count": 99, "start_date": "2009-09", "completion_date": "2010-09", "has_results": false, "last_update_posted_date": "2012-01-23", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 24, "location_summary": "Scottsdale, Arizona • Tucson, Arizona • Irvine, California + 21 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Irvine", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "DeLand", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00985127" }, { "nct_id": "NCT01925261", "title": "A Study Evaluating the Safety and Efficacy of Intra-articular Injections of TPX-100 in Subjects With Mild to Moderate Patello-Femoral Osteoarthritis Involving Both Knees", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Knee Osteoarthritis" ], "interventions": [ { "name": "TPX-100 50mg", "type": "DRUG" }, { "name": "TPX-100 100mg", "type": "DRUG" }, { "name": "TPX-100 200mg", "type": "DRUG" }, { "name": "TPX-100 20mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "OrthoTrophix, Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "25 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "25 Years to 75 Years" }, "enrollment_count": 120, "start_date": "2014-01", "completion_date": "2016-09", "has_results": false, "last_update_posted_date": "2017-04-21", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 1, "location_summary": "Seattle, Washington", "locations": [ { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT01925261" }, { "nct_id": "NCT00533897", "title": "Phase IIIB Subcutaneous Missed Dose Study", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Abatacept", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 270, "start_date": "2007-11", "completion_date": "2014-02", "has_results": true, "last_update_posted_date": "2015-04-23", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 13, "location_summary": "Los Angeles, California • Trumbull, Connecticut • Sarasota, Florida + 10 more", "locations": [ { "city": "Los Angeles", "state": "California" }, { "city": "Trumbull", "state": "Connecticut" }, { "city": "Sarasota", "state": "Florida" }, { "city": "Indianapolis", "state": "Indiana" }, { "city": "Cumberland", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT00533897" }, { "nct_id": "NCT01851070", "title": "A Multi-center Study a Single IV Infusion of Allogeneic MPCs in Patients With Rheumatoid Arthritis and Incomplete Response to at Least One TNFα Inhibitor", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Rheumatoid Arthritis" ], "interventions": [ { "name": "Allogeneic Mesenchymal Precursor Cells", "type": "DRUG" }, { "name": "Normal Saline", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mesoblast, Ltd.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 48, "start_date": "2013-07", "completion_date": "2017-03", "has_results": false, "last_update_posted_date": "2020-06-26", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 20, "location_summary": "Anniston, Alabama • Gilbert, Arizona • El Cajon, California + 17 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "El Cajon", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Upland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01851070" }, { "nct_id": "NCT02962362", "title": "Study to Assess Exactech's Guided Personalized Surgery eGPS® in Total Knee Arthroplasty", "overall_status": "TERMINATED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Osteoarthritis" ], "interventions": [], "intervention_types": [], "sponsor": "Exactech", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 73, "start_date": "2016-08", "completion_date": "2021-11", "has_results": false, "last_update_posted_date": "2022-09-01", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 1, "location_summary": "Gainesville, Florida", "locations": [ { "city": "Gainesville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02962362" }, { "nct_id": "NCT07403188", "title": "A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101", "overall_status": "RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Refractory Lupus Nephritis", "Myasthaenia Gravis", "Stiff Person Syndrome", "Rheumatoid Arthritis (RA)", "Multiple Sclerosis", "Dermatomyositis", "Systemic Sclerosis (SSc)" ], "interventions": [ { "name": "KYV-101", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Kyverna Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 70, "start_date": "2025-11-24", "completion_date": "2041-01", "has_results": false, "last_update_posted_date": "2026-02-11", "last_synced_at": "2026-10-22T16:58:30.211Z", "location_count": 1, "location_summary": "Denver, Colorado", "locations": [ { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT07403188" } ] }